Points to Consider Regarding Tobacco Hindrance

Negar Rezaei ¹, Farshad Farzadfar ¹ *

Cited by CrossRef: 4

1- Singh S, Kumar S, Kashyap G, Ward K. Tobacco Use and Cessation among a Nationally Representative Sample of Men in India, 2019–2021. J Smok Cessat. 2023;2023 [Crossref]

2- Heidari-Foroozan M, Aryan A, Esfahani Z, Shahrbaf M, Moghaddam S, Keykhaei M, Ghasemi E, Rashidi M, Rezaei N, Ghamari S, Abbasi-Kangevari M, Fateh S, Farzi Y, Rezaei N, Larijani B. National, subnational and risk attributed burden of chronic respiratory diseases in Iran from 1990 to 2019. Respir Res. 2023;24(1) [Crossref]

3- Fallahzadeh A, Sharifnejad Tehrani Y, Sheikhy A, Ghamari S, Mohammadi E, Saeedi Moghaddam S, Esfahani Z, Nasserinejad M, Shobeiri P, Rashidi M, Rezaei N, Heidari-Foroozan M, Rezaei N, Larijani B, Farzadfar F. The burden of chronic respiratory disease and attributable risk factors in North Africa and Middle East: findings from global burden of disease study (GBD) 2019. Respir Res. 2022;23(1) [Crossref]

4- Ghamari A, Rezaei N, Ranjbar M, Farzadfar F. The effect of hookah use on COVID-19 related adverse outcomes: Lessons learned from integrating STEPs 2016 and national COVID-19 registration databases. Tob Induc Dis. 2022;20(January):1 [Crossref]

Submit Your Paper Notification Instructions for Authors Aims and Scope Editorial policies Editorial Board AIM old site Archive

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.